Vera Therapeutics' Atacicept has shown promising results in IgA nephropathy, leading to significant stock gains. But read why I'm cautious of entering VERA stock.
Meanwhile, synthetic gel aids in recovery after spinal surgery; Pittsburgh researchers create helper robots for people with ALS; a study finds nerve stimulation is effective against ...